Oral News and Research

RSS

C3 Jian, West China School of Stomatology to create joint CRC to test oral healthcare products

C3 Jian, Inc.'s Board of Directors today announced that the Company has signed an agreement with the West China School of Stomatology at Sichuan University to create a joint Clinical Research Centre to test new oral healthcare products in human clinical trials.

30 Apr 2011

Health practitioners need to assess health literacy to overcome barrier to quality care: MD Anderson nurse

Low health literacy is a significant barrier to quality care, especially among elderly patients, but increased use of simple and effective health literacy assessment tests by nurses and clinicians can help improve communication and health outcomes.

30 Apr 2011

AACN to present Flame of Excellence Award to VCU researcher

The American Association of Critical-Care Nurses will present the Flame of Excellence Award to noted researcher and educator Mary Jo Grap, RN, PhD, FAAN, professor, School of Nursing, Virginia Commonwealth University, Richmond.

30 Apr 2011

ETP makes investment to support development of ICVrx's targeted epilepsy drug technology

Epilepsy Therapy Project, a non-profit organization whose mission is to accelerate new therapies for people living with epilepsy and seizures, and ICVrx, LLC, a pharmacy product research and development company focused on novel therapies for central nervous system disorders, announced today that ETP has made an investment in ICVrx to support the development of ICVrx's targeted epilepsy drug technology for patients whose seizures are not controlled by current therapies.

30 Apr 2011

CEL-SCI receives no objection letter to initiate Phase III clinical trial of Multikine in Canada

CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.

30 Apr 2011

Symposium to examine bidirectional relationship between oral health and diabetes

Some 65 percent of people in the US have periodontal disease, but that rate jumps to 90 percent among individuals with diabetes. While the links between oral disease and other systemic health issues are now well known, there continues to be little to no connection between medical and dental care for diabetic patients.

29 Apr 2011

Top-line results from Pfizer's tofacitinib Phase 3 studies in RA

Pfizer Inc. announced today top-line results from the ORAL Standard and ORAL Step Phase 3 studies of tofacitinib, an investigational, novel, oral JAK inhibitor.

29 Apr 2011

Viewpoints: Taking the deficit seriously; despite low numbers, high-risk pools are succeeding

The deficit debate, now fully engaged, is also an evaluation of political seriousness. House Republican leaders have passed the test, supporting a politically risky budget that changes Medicare into a premium-support program and eventually returns federal spending to sustainable levels.

28 Apr 2011

CEL-SCI initiates Multikine Phase III trial in head and neck cancer

CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, at the Meenakshi Mission Hospital and Research Centre in Madurai, Tamil Nadu, India, the first clinical site in India.

28 Apr 2011

Curis reports first quarter net loss of $6.8 million

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the first quarter ended March 31, 2011.

28 Apr 2011

Celgene non-GAAP total revenue increases 40% to $1.11 billion

Celgene Corporation: “The results for the quarter were outstanding and they reflect the ongoing momentum that Celgene is creating as we leverage our business model and position our Company for long-term success”.

28 Apr 2011

Justices question Vermont's effort to restrict drug data mining

During Tuesday's oral arguments, the justices suggested that the state law, which restricts pharmaceutical marketers' ability to obtain data on doctor prescribing habits, may violate free-speech rights.

28 Apr 2011

Enrollment complete in Unigene's oral PTH Phase 2 osteoporosis study in postmenopausal women

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the Company has completed patient enrollment of its Phase 2 study with an experimental oral parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.

28 Apr 2011

Study clarifies ginkgo's pain-reducing effects

Experiments in rats show that a standardized ginkgo extract—injected either into the spinal canal or directly into the injured area—effectively reduces inflammation and some types of pain, according to a report in the May issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

28 Apr 2011

First Edition: April 27, 2011

In today's headlines, political push-back continues regarding the Paul Ryan budget plan and the Supreme Court seems skeptical that prescription drug data laws don't violate free speech.

27 Apr 2011

High Court hears arguments regarding access to docs' prescribing data

In this case, the state of Vermont is battling drug companies and data-mining firms. Vermont's law bans the sale of prescribing information unless physicians "opt in" and make their records available.

27 Apr 2011

Court's rejection of fast-track request raises questions, issues

The court's online order did not offer any legal reasoning, nor were dissenting opinions noted. However, Justice Elena Kagan did participate in the decision. Meanwhile, Politico Pro explores some of the key questions that will be at stake surrounding the law's "individual mandate" as the challenges now wind through through the federal appeals courts this summer.

27 Apr 2011

Boehringer Ingelheim initiates enrollment in BI 201335 Phase 3 clinical trial for chronic HCV

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that enrollment has commenced at North American sites in its pivotal Phase 3 clinical trial program for BI 201335, the Company's investigational, oral protease inhibitor for the treatment of chronic hepatitis C virus (HCV).

27 Apr 2011

Researchers develop protein-based inhibitor that can treat HPV

Human papillomavirus causes cervical cancer, the second most common cause of cancer death for women, and is a common cause of anogenital and some head and neck cancers.

27 Apr 2011

Diabetes and prediabetes are on the rise: New medication in research trials

As the newest statistics from the CDC show, diabetes is an ever increasing problem for Americans. Almost 26 million adults in this country now have diabetes, an increase of 9% since 2008. Ninety to 95% of cases are type 2 diabetes, marked by a gradual inability of the body’s cells to respond to insulin, and eventually an inability to produce enough insulin. In addition, almost 79 million people in this country have prediabetes. The CDC has warned that if diabetes continues on its current course, it could affect a third of all adult Americans by 2050.

26 Apr 2011

Oral News and Research

C3 Jian, West China School of Stomatology to create joint CRC to test oral healthcare products

Health practitioners need to assess health literacy to overcome barrier to quality care: MD Anderson nurse

AACN to present Flame of Excellence Award to VCU researcher

ETP makes investment to support development of ICVrx's targeted epilepsy drug technology

CEL-SCI receives no objection letter to initiate Phase III clinical trial of Multikine in Canada

Symposium to examine bidirectional relationship between oral health and diabetes

Top-line results from Pfizer's tofacitinib Phase 3 studies in RA

Viewpoints: Taking the deficit seriously; despite low numbers, high-risk pools are succeeding

CEL-SCI initiates Multikine Phase III trial in head and neck cancer

Curis reports first quarter net loss of $6.8 million

Celgene non-GAAP total revenue increases 40% to $1.11 billion

Justices question Vermont's effort to restrict drug data mining

Enrollment complete in Unigene's oral PTH Phase 2 osteoporosis study in postmenopausal women

Study clarifies ginkgo's pain-reducing effects

First Edition: April 27, 2011

High Court hears arguments regarding access to docs' prescribing data

Court's rejection of fast-track request raises questions, issues

Boehringer Ingelheim initiates enrollment in BI 201335 Phase 3 clinical trial for chronic HCV

Researchers develop protein-based inhibitor that can treat HPV

Diabetes and prediabetes are on the rise: New medication in research trials

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News